The tumor‐specific nanosensitizer switched from the “off” to “on” state to exert therapeutic efficacy at the tumor site under US irradiation, enabling the GSH‐activated sonodynamic process and concomitantly inducing downregulation of GPX4. This evidence concerns the gene GPX4 and neoplasm.